UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Olanzapine/Fluoxetine Combination in Children and Adolescents With Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Trial

Journal of the American Academy of Child and Adolescent Psychiatry, 2015-03, Vol.54 (3), p.217-224

2015

Volltextzugriff (PDF)

Prognostic factors for changes in the timed 4-stair climb in patients with Duchenne muscular dystrophy, and implications for measuring drug efficacy: A multi-institutional collaboration

PloS one, 2020-06, Vol.15 (6), p.e0232870-e0232870

2020

Volltextzugriff (PDF)

Efficacy and safety of olanzapine/fluoxetine combination vs fluoxetine monotherapy following successful combination therapy of treatment-resistant major depressive disorder

Neuropsychopharmacology (New York, N.Y.), 2014-10, Vol.39 (11), p.2549-2559

2014

Volltextzugriff (PDF)

Lanabecestat: Neuroimaging results in early symptomatic Alzheimer's disease

Alzheimer's & dementia : translational research & clinical interventions, 2021, Vol.7 (1), p.e12123-n/a

2021

Volltextzugriff (PDF)

Hemorrhage control by law enforcement personnel: a survey of knowledge translation from the military combat experience

Military medicine, 2015-06, Vol.180 (6), p.615-620

2015

Volltextzugriff (PDF)

Effects of Renal Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide

Clinical pharmacokinetics, 2021-08, Vol.60 (8), p.1049-1059

2021

Volltextzugriff (PDF)

Postinjection delirium/sedation syndrome in patients with schizophrenia receiving olanzapine long-acting injection: Results from a large observational study

BJPsych open, 2017-07, Vol.3 (4), p.186-192

2017

Volltextzugriff (PDF)

Comparison of strain-gage and fiber-optic goniometry for measuring knee kinematics during activities of daily living and exercise

Journal of biomechanical engineering, 2012-08, Vol.134 (8), p.084502

2012

Volltextzugriff (PDF)

Quality of life in children and adolescents with bipolar I depression treated with olanzapine/fluoxetine combination

Child and adolescent psychiatry and mental health, 2017-07, Vol.11 (1), p.34-34, Article 34

2017

Volltextzugriff (PDF)

What Psychiatrists Need to Know About the Determination of Dispositional Capacity

The Psychiatric times, 2018-04, Vol.35 (4), p.6

2018

Volltextzugriff (PDF)

Effects of Hepatic Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide

Clinical pharmacokinetics, 2022-07, Vol.61 (7), p.1057-1067

2022

Volltextzugriff (PDF)

971-P: Renal Impairment Has No Impact on the Clinical Pharmacokinetics of Tirzepatide

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials

JAMA neurology, 2020-02, Vol.77 (2), p.199

2020

Volltextzugriff (PDF)

Deflazacort vs prednisone treatment for Duchenne muscular dystrophy: A meta‐analysis of disease progression rates in recent multicenter clinical trials

Muscle & nerve, 2020-01, Vol.61 (1), p.26-35

2020

Volltextzugriff (PDF)

Pharmacokinetics and safety of tadalafil in a paediatric population with pulmonary arterial hypertension: A multiple ascending‐dose study

British journal of clinical pharmacology, 2019-10, Vol.85 (10), p.2302-2309

2019

Volltextzugriff (PDF)

Using Cross-Checking Safety Tools, Decision Support, and Education Within the Electronic Medical Record to Increase Concordant Advance Care Planning Orders (QI728)

Journal of pain and symptom management, 2021-03, Vol.61 (3), p.667-667

2021

Volltextzugriff (PDF)

Investigation of the Effect of Lasmiditan on the Pharmacokinetics of P-Glycoprotein and Breast Cancer Resistance Protein Substrates

Journal of clinical pharmacology, 2024-01, Vol.64 (1), p.94-102

2024

Volltextzugriff (PDF)

A 52-Week Study of Olanzapine with a Randomized Behavioral Weight Counseling Intervention in Adolescents with Schizophrenia or Bipolar I Disorder

Journal of child and adolescent psychopharmacology, 2016-12, Vol.26 (10), p.922-934

2016

Volltextzugriff (PDF)

Human-Automation Interaction: Transportation

1, 2022

Volltextzugriff (PDF)

Within-drug benefit-risk evaluation of olanzapine long-acting injection at one and two years of treatment

International journal of methods in psychiatric research, 2014-12, Vol.23 (4), p.439-450

2014

Volltextzugriff (PDF)

Leading With Hope: A Qualitative Study Assessing Hope to Drive Improved Client Outcomes

Landry, Scotty John

2023

Volltextzugriff (PDF)

Baseline characteristics and hospitalizations in patients with schizophrenia receiving olanzapine long-acting injection: an interim analysis from a non-interventional, prospective observational safety study

BMC psychiatry, 2015-11, Vol.15 (278), p.278-278, Article 278

2015

Volltextzugriff (PDF)

Clinical outcomes with olanzapine long-acting injection: impact of the 3-hour observation period on patient satisfaction and well-being

Neuropsychiatric disease and treatment, 2016-01, Vol.12, p.2737-2743

2016

Volltextzugriff (PDF)

Playing at learning: why knowledge creation needs fun

PROC HAWAII INT CONF SYST SCI, 2000, p.71-71

Landry, John R

2000

Volltextzugriff (PDF)

Poster #215 COMPARISON OF OUTCOMES IN PATIENTS WITH EARLY PHASE VERSUS LATER PHASE SCHIZOPHRENIA

Schizophrenia research, 2012-04, Vol.136, p.S263-S263

2012

Volltextzugriff (PDF)

1 – 25 von 937

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(529)
Mit Volltextzugriff
(802)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Olanzapine/Fluoxetine Combination in Children and Adolescents With Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Trial

Prognostic factors for changes in the timed 4-stair climb in patients with Duchenne muscular dystrophy, and implications for measuring drug efficacy: A multi-institutional collaboration

Efficacy and safety of olanzapine/fluoxetine combination vs fluoxetine monotherapy following successful combination therapy of treatment-resistant major depressive disorder

Lanabecestat: Neuroimaging results in early symptomatic Alzheimer's disease

Hemorrhage control by law enforcement personnel: a survey of knowledge translation from the military combat experience

Effects of Renal Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide

Postinjection delirium/sedation syndrome in patients with schizophrenia receiving olanzapine long-acting injection: Results from a large observational study

Comparison of strain-gage and fiber-optic goniometry for measuring knee kinematics during activities of daily living and exercise

Quality of life in children and adolescents with bipolar I depression treated with olanzapine/fluoxetine combination

What Psychiatrists Need to Know About the Determination of Dispositional Capacity

Effects of Hepatic Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide

971-P: Renal Impairment Has No Impact on the Clinical Pharmacokinetics of Tirzepatide

Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials

Deflazacort vs prednisone treatment for Duchenne muscular dystrophy: A meta‐analysis of disease progression rates in recent multicenter clinical trials

Pharmacokinetics and safety of tadalafil in a paediatric population with pulmonary arterial hypertension: A multiple ascending‐dose study

Using Cross-Checking Safety Tools, Decision Support, and Education Within the Electronic Medical Record to Increase Concordant Advance Care Planning Orders (QI728)

Investigation of the Effect of Lasmiditan on the Pharmacokinetics of P-Glycoprotein and Breast Cancer Resistance Protein Substrates

A 52-Week Study of Olanzapine with a Randomized Behavioral Weight Counseling Intervention in Adolescents with Schizophrenia or Bipolar I Disorder

Human-Automation Interaction: Transportation

Within-drug benefit-risk evaluation of olanzapine long-acting injection at one and two years of treatment

Leading With Hope: A Qualitative Study Assessing Hope to Drive Improved Client Outcomes

Baseline characteristics and hospitalizations in patients with schizophrenia receiving olanzapine long-acting injection: an interim analysis from a non-interventional, prospective observational safety study

Clinical outcomes with olanzapine long-acting injection: impact of the 3-hour observation period on patient satisfaction and well-being

Playing at learning: why knowledge creation needs fun

Poster #215 COMPARISON OF OUTCOMES IN PATIENTS WITH EARLY PHASE VERSUS LATER PHASE SCHIZOPHRENIA

Suchergebnisse filtern